Safety and therapeutic effect of mesenchymal stem cell infusion on moderate to severe ulcerative colitis.

Exp Ther Med · 2016 · PMC5103734 · PMID 27882104

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

failed to reach statistical significanceP>0.05actually significant

Although IBDQ scores steadily increased in group II throughout the trial, the change in scores failed to reach statistical significance by the end of the trial (P>0.05).

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.